{"transactions":[{"id":696385,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-08-05T20:02:30.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":false,"shares":52744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on August 1, 2022, with 52,742 vested on each of August 1, 2023, August 1, 2024 and August 1, 2025, and 52,744 vested on August 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on August 1, 2022, with 52,742 vested on each of August 1, 2023, August 1, 2024 and August 1, 2025, and 52,744 vested on August 1, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":52744},"source":{"system":"sec-edgar","filing":"0001193125-26-335012","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526335012/ownership.xml","form_type":"4"}},{"id":696384,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-08-05T20:02:30.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":25578,"price":34.8757,"value":892050.6546,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.66 to $35.07, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":134877,"source":{"system":"sec-edgar","filing":"0001193125-26-335012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526335012/ownership.xml","form_type":"4"}},{"id":696383,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-08-05T20:02:30.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":true,"shares":52744,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":160455,"source":{"system":"sec-edgar","filing":"0001193125-26-335012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526335012/ownership.xml","form_type":"4"}},{"id":740204,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T20:05:05.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":25800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 11, 2027 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":25800,"derivative":{"exercise_price":17.1,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":25800},"source":{"system":"sec-edgar","filing":"0001193125-26-269348","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938678/000119312526269348/ownership.xml","form_type":"4"}},{"id":854919,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:14:56.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":false,"shares":19654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 19,654 vested on March 5, 2026, and 19,654 vesting on each of March 5, 2027, March 5, 2028 and March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 19,654 vested on March 5, 2026, and 19,654 vesting on each of March 5, 2027, March 5, 2028 and March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":58962,"derivative":{"underlying":"Ordinary Shares","underlying_shares":19654},"source":{"system":"sec-edgar","filing":"0001193125-26-098524","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098524/ownership.xml","form_type":"4"}},{"id":854918,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:14:56.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":9533,"price":31.6684,"value":301894.8572,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 to $32.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":107711,"source":{"system":"sec-edgar","filing":"0001193125-26-098524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098524/ownership.xml","form_type":"4"}},{"id":854917,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:14:56.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":true,"shares":19654,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":117244,"source":{"system":"sec-edgar","filing":"0001193125-26-098524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098524/ownership.xml","form_type":"4"}},{"id":857149,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:09:57.000Z","date":"2026-03-04","kind":"grant","planned":true,"acquired":true,"shares":50643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2026, with 12,660 vesting on each of March 4, 2027, March 4, 2028 and March 4, 2029, and 12,663 vesting on March 4, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2026, with 12,660 vesting on each of March 4, 2027, March 4, 2028 and March 4, 2029, and 12,663 vesting on March 4, 2030."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":50643,"derivative":{"underlying":"Ordinary Shares","underlying_shares":50643},"source":{"system":"sec-edgar","filing":"0001193125-26-096520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096520/ownership.xml","form_type":"4"}},{"id":857148,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:09:57.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":false,"shares":23251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 4, 2024, with 23,251 vested on each of March 4, 2025 and March 4, 2026, 23,251 vesting on March 4, 2027, and 23,252 vesting on March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 4, 2024, with 23,251 vested on each of March 4, 2025 and March 4, 2026, 23,251 vesting on March 4, 2027, and 23,252 vesting on March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":46503,"derivative":{"underlying":"Ordinary Shares","underlying_shares":23251},"source":{"system":"sec-edgar","filing":"0001193125-26-096520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096520/ownership.xml","form_type":"4"}},{"id":857147,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:09:57.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":11277,"price":32.4645,"value":366102.1665,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.095 to $33.30, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":97590,"source":{"system":"sec-edgar","filing":"0001193125-26-096520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096520/ownership.xml","form_type":"4"}},{"id":857146,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:09:57.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":true,"shares":23251,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":108867,"source":{"system":"sec-edgar","filing":"0001193125-26-096520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096520/ownership.xml","form_type":"4"}},{"id":859904,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-03-05T21:01:11.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":false,"shares":141478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were earned on January 27, 2026, as a result of the satisfaction of certain performance criteria certified by the Human Resources and Compensation Committee and subsequently vested on March 3, 2026, following satisfaction of the time-based vesting criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were earned on January 27, 2026, as a result of the satisfaction of certain performance criteria certified by the Human Resources and Compensation Committee and subsequently vested on March 3, 2026, following satisfaction of the time-based vesting criteria."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":141478},"source":{"system":"sec-edgar","filing":"0001193125-26-093896","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093896/ownership.xml","form_type":"4"}},{"id":859903,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-03-05T21:01:11.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":false,"shares":24900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 24,900 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 24,900 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":24901,"derivative":{"underlying":"Ordinary Shares","underlying_shares":24900},"source":{"system":"sec-edgar","filing":"0001193125-26-093896","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093896/ownership.xml","form_type":"4"}},{"id":859902,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:01:11.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":68685,"price":32.3599,"value":2222639.7315,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.72 to $32.865, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":85616,"source":{"system":"sec-edgar","filing":"0001193125-26-093896","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093896/ownership.xml","form_type":"4"}},{"id":859901,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:01:11.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":true,"shares":141478,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":154301,"source":{"system":"sec-edgar","filing":"0001193125-26-093896","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093896/ownership.xml","form_type":"4"}},{"id":859900,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:01:11.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":12077,"price":32.3599,"value":390810.5123,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.72 to $32.865, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":12823,"source":{"system":"sec-edgar","filing":"0001193125-26-093896","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093896/ownership.xml","form_type":"4"}},{"id":859899,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:01:11.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":true,"shares":24900,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":24900,"source":{"system":"sec-edgar","filing":"0001193125-26-093896","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093896/ownership.xml","form_type":"4"}},{"id":928300,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-01-29T21:05:58.000Z","date":"2026-01-27","kind":"grant","planned":false,"acquired":true,"shares":141478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 3, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 3, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":141478,"derivative":{"underlying":"Ordinary Shares","underlying_shares":141478},"source":{"system":"sec-edgar","filing":"0001193125-26-029329","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526029329/ownership.xml","form_type":"4"}},{"id":1075564,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2025-08-05T20:02:24.000Z","date":"2025-08-01","kind":"exercise","planned":true,"acquired":false,"shares":52742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on August 1, 2022, with 52,742 vested on each of August 1, 2023, August 1, 2024 and August 1, 2025, and 52,744 vesting on August 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on August 1, 2022, with 52,742 vested on each of August 1, 2023, August 1, 2024 and August 1, 2025, and 52,744 vesting on August 1, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":52744,"derivative":{"underlying":"Ordinary Shares","underlying_shares":52742},"source":{"system":"sec-edgar","filing":"0000950170-25-102977","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025102977/ownership.xml","form_type":"4"}},{"id":1075563,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2025-08-05T20:02:24.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":52742,"price":15.1575,"value":799436.865,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.13 to $15.31, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-102977","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025102977/ownership.xml","form_type":"4"}},{"id":1075562,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2025-08-05T20:02:24.000Z","date":"2025-08-01","kind":"exercise","planned":true,"acquired":true,"shares":52742,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":52742,"source":{"system":"sec-edgar","filing":"0000950170-25-102977","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025102977/ownership.xml","form_type":"4"}},{"id":1110002,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-16T20:05:11.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":30700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2026 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":30700,"derivative":{"exercise_price":4.91,"expiration_date":"2035-06-13","underlying":"Common Stock","underlying_shares":30700},"source":{"system":"sec-edgar","filing":"0000950170-25-086704","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938678/000095017025086704/ownership.xml","form_type":"4"}},{"id":1218513,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2025-03-07T21:16:45.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":78616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 5, 2025, with 19,654 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028 and March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 5, 2025, with 19,654 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028 and March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":78616,"derivative":{"underlying":"Ordinary Shares","underlying_shares":78616},"source":{"system":"sec-edgar","filing":"0000950170-25-035522","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025035522/ownership.xml","form_type":"4"}},{"id":1220815,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2025-03-06T21:11:09.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":false,"shares":23251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 4, 2024, with 23,251 vested on March 4, 2025, 23,251 vesting on each of March 4, 2026 and March 4, 2027, and 23,252 vesting on March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 4, 2024, with 23,251 vested on March 4, 2025, 23,251 vesting on each of March 4, 2026 and March 4, 2027, and 23,252 vesting on March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":69754,"derivative":{"underlying":"Ordinary Shares","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0000950170-25-034636","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034636/ownership.xml","form_type":"4"}},{"id":1220814,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:11:09.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":8077,"price":15.9132,"value":128530.9164,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reportin person on November 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.68 to $16.13, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-034636","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034636/ownership.xml","form_type":"4"}},{"id":1220813,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:11:09.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":15174,"price":15.7346,"value":238756.8204,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reportin person on November 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.28 to $16.015, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":8077,"source":{"system":"sec-edgar","filing":"0000950170-25-034636","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034636/ownership.xml","form_type":"4"}},{"id":1220812,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:11:09.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":true,"shares":23251,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":23251,"source":{"system":"sec-edgar","filing":"0000950170-25-034636","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034636/ownership.xml","form_type":"4"}},{"id":1224655,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2025-03-05T21:08:42.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":false,"shares":24900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 24,900 vested on each of March 3, 2024 and March 3, 2025, 24,900 vesting on March 3, 2026, and 24,901 vesting on March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 24,900 vested on each of March 3, 2024 and March 3, 2025, 24,900 vesting on March 3, 2026, and 24,901 vesting on March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":49801,"derivative":{"underlying":"Ordinary Shares","underlying_shares":24900},"source":{"system":"sec-edgar","filing":"0000950170-25-033557","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025033557/ownership.xml","form_type":"4"}},{"id":1224654,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2025-03-05T21:08:42.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":5174,"price":15.5576,"value":80495.0224,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.455 to $15.75, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-033557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025033557/ownership.xml","form_type":"4"}},{"id":1224653,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2025-03-05T21:08:42.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":19726,"price":16.1855,"value":319275.173,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.86 to $16.53, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5174,"source":{"system":"sec-edgar","filing":"0000950170-25-033557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025033557/ownership.xml","form_type":"4"}},{"id":1224652,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2025-03-05T21:08:42.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":true,"shares":24900,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":24900,"source":{"system":"sec-edgar","filing":"0000950170-25-033557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025033557/ownership.xml","form_type":"4"}},{"id":1332623,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T14:05:04.000Z","date":"2024-12-11","kind":"grant","planned":false,"acquired":true,"shares":44200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 36 substantially equal monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":44200,"derivative":{"exercise_price":8.51,"expiration_date":"2034-12-10","underlying":"Common Stock","underlying_shares":44200},"source":{"system":"sec-edgar","filing":"0000950170-24-136056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938678/000095017024136056/ownership.xml","form_type":"4"}},{"id":1435390,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2024-08-13T20:02:28.000Z","date":"2024-08-09","kind":"sale","planned":false,"acquired":false,"shares":45060,"price":17.3762,"value":782971.572,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.371 to $17.405, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-096138","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024096138/ownership.xml","form_type":"4"}},{"id":1441649,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2024-08-05T11:35:20.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":false,"shares":52742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on August 1, 2022, with 52,742 vested on each of August 1, 2023 and August 1, 2024, 52,742 vesting on August 1, 2025, and 52,744 vesting on August 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on August 1, 2022, with 52,742 vested on each of August 1, 2023 and August 1, 2024, 52,742 vesting on August 1, 2025, and 52,744 vesting on August 1, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":105486,"derivative":{"underlying":"Ordinary Shares","underlying_shares":52742},"source":{"system":"sec-edgar","filing":"0000950170-24-090329","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024090329/ownership.xml","form_type":"4"}},{"id":1441648,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2024-08-05T11:35:20.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":24537,"price":17.2507,"value":423280.4259,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.2502 to $17.2550, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":45060,"source":{"system":"sec-edgar","filing":"0000950170-24-090329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024090329/ownership.xml","form_type":"4"}},{"id":1441647,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2024-08-05T11:35:20.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":true,"shares":52742,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":69597,"source":{"system":"sec-edgar","filing":"0000950170-24-090329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024090329/ownership.xml","form_type":"4"}},{"id":1600190,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2024-03-05T21:16:42.000Z","date":"2024-03-04","kind":"grant","planned":true,"acquired":true,"shares":93005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2024, with 23,251 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 23,252 vesting on March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2024, with 23,251 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 23,252 vesting on March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":93005,"derivative":{"underlying":"Ordinary Shares","underlying_shares":93005},"source":{"system":"sec-edgar","filing":"0000950170-24-025943","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024025943/ownership.xml","form_type":"4"}},{"id":1600189,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2024-03-05T21:16:42.000Z","date":"2024-03-03","kind":"exercise","planned":true,"acquired":false,"shares":24900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":74701,"derivative":{"underlying":"Ordinary Shares","underlying_shares":24900},"source":{"system":"sec-edgar","filing":"0000950170-24-025943","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024025943/ownership.xml","form_type":"4"}},{"id":1600188,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2024-03-05T21:16:42.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":8045,"price":13.3373,"value":107298.5785,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.445, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":16855,"source":{"system":"sec-edgar","filing":"0000950170-24-025943","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024025943/ownership.xml","form_type":"4"}},{"id":1600187,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2024-03-05T21:16:42.000Z","date":"2024-03-03","kind":"exercise","planned":true,"acquired":true,"shares":24900,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":24900,"source":{"system":"sec-edgar","filing":"0000950170-24-025943","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024025943/ownership.xml","form_type":"4"}},{"id":1817195,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2023-08-03T11:09:16.000Z","date":"2023-08-01","kind":"exercise","planned":true,"acquired":false,"shares":52742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on August 1, 2022, with 52,742 vesting on each of August 1, 2023, August 1, 2024 and August 1, 2025, and 52,744 vesting on August 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on August 1, 2022, with 52,742 vesting on each of August 1, 2023, August 1, 2024 and August 1, 2025, and 52,744 vesting on August 1, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":158228,"derivative":{"underlying":"Ordinary Shares","underlying_shares":52742},"source":{"system":"sec-edgar","filing":"0001209191-23-044313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123044313/doc4.xml","form_type":"4"}},{"id":1817194,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2023-08-03T11:09:16.000Z","date":"2023-08-01","kind":"sale","planned":true,"acquired":false,"shares":52742,"price":8.2987,"value":437690.0354,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.290 to $8.315, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-044313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123044313/doc4.xml","form_type":"4"}},{"id":1817193,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2023-08-03T11:09:16.000Z","date":"2023-08-01","kind":"exercise","planned":true,"acquired":true,"shares":52742,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":52742,"source":{"system":"sec-edgar","filing":"0001209191-23-044313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123044313/doc4.xml","form_type":"4"}},{"id":1967227,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:07:12.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":99601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":99601,"derivative":{"underlying":"Ordinary Shares","underlying_shares":99601},"source":{"system":"sec-edgar","filing":"0001209191-23-016706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016706/doc4.xml","form_type":"4"}},{"id":2196604,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2022-08-03T11:14:19.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":210970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on August 1, 2022, with 52,742 vesting on each of August 1, 2023, August 1, 2024 and August 1, 2025 and 52,744 vesting on August 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on August 1, 2022, with 52,742 vesting on each of August 1, 2023, August 1, 2024 and August 1, 2025 and 52,744 vesting on August 1, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":210970,"derivative":{"underlying":"Ordinary Shares","underlying_shares":210970},"source":{"system":"sec-edgar","filing":"0001209191-22-044028","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122044028/doc4.xml","form_type":"4"}}]}